171 related articles for article (PubMed ID: 9855502)
21. Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease.
Fukuda M; Kanou F; Shimada N; Sawabe M; Saito Y; Murayama S; Hashimoto M; Maruyama N; Ishigami A
Biomed Res; 2009 Aug; 30(4):227-33. PubMed ID: 19729853
[TBL] [Abstract][Full Text] [Related]
22. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
23. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
24. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures.
Lovell MA; Xie C; Markesbery WR
Free Radic Biol Med; 2000 Oct; 29(8):714-20. PubMed ID: 11053772
[TBL] [Abstract][Full Text] [Related]
25. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.
Lovell MA; Gabbita SP; Markesbery WR
J Neurochem; 1999 Feb; 72(2):771-6. PubMed ID: 9930752
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease.
Kazemifar S; Manning KY; Rajakumar N; Gómez FA; Soddu A; Borrie MJ; Menon RS; Bartha R;
PLoS One; 2017; 12(6):e0178529. PubMed ID: 28582450
[TBL] [Abstract][Full Text] [Related]
27. 4-hydroxynonenal detoxification by mitochondrial glutathione S-transferase is compromised by short-term ethanol consumption in rats.
Chen J; Schenker S; Henderson GI
Alcohol Clin Exp Res; 2002 Aug; 26(8):1252-8. PubMed ID: 12198402
[TBL] [Abstract][Full Text] [Related]
28. Hypocretin (orexin) loss in Alzheimer's disease.
Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF
Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124
[TBL] [Abstract][Full Text] [Related]
29. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
Reed T; Perluigi M; Sultana R; Pierce WM; Klein JB; Turner DM; Coccia R; Markesbery WR; Butterfield DA
Neurobiol Dis; 2008 Apr; 30(1):107-20. PubMed ID: 18325775
[TBL] [Abstract][Full Text] [Related]
30. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
31. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
32. Lifespan and stress resistance of Caenorhabditis elegans are increased by expression of glutathione transferases capable of metabolizing the lipid peroxidation product 4-hydroxynonenal.
Ayyadevara S; Engle MR; Singh SP; Dandapat A; Lichti CF; Benes H; Shmookler Reis RJ; Liebau E; Zimniak P
Aging Cell; 2005 Oct; 4(5):257-71. PubMed ID: 16164425
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
Montine TJ; Markesbery WR; Morrow JD; Roberts LJ
Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
[TBL] [Abstract][Full Text] [Related]
34. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.
Liu RY; Zhou JN; van Heerikhuize J; Hofman MA; Swaab DF
J Clin Endocrinol Metab; 1999 Jan; 84(1):323-7. PubMed ID: 9920102
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
Edsbagge M; Andreasson U; Ambarki K; Wikkelsø C; Eklund A; Blennow K; Zetterberg H; Tullberg M
J Alzheimers Dis; 2017; 58(3):821-828. PubMed ID: 28505972
[TBL] [Abstract][Full Text] [Related]
36. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
[TBL] [Abstract][Full Text] [Related]
37. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
Reinikainen KJ; Soininen H; Riekkinen PJ
J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
[TBL] [Abstract][Full Text] [Related]
38. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of 4-hydroxynonenal by rat Kupffer cells.
Luckey SW; Petersen DR
Arch Biochem Biophys; 2001 May; 389(1):77-83. PubMed ID: 11370675
[TBL] [Abstract][Full Text] [Related]
40. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
